Please provide your email address to receive an email when new articles are posted on . The American College of Gastroenterology has released updated guidelines on the diagnosis and management of ...

As Dr. Jordan Axelrad of NYU Grossman explains in detail, the process of maintaining remission and curbing relapse in patients hospitalized because of ulcerative colitis begins with the question "What ...

Credit: Getty Images. Medications for ulcerative colitis include first-line therapy 5-ASA for mild cases as well as immune system–altering biologics for more severe cases. The initial treatment with ...

Please provide your email address to receive an email when new articles are posted on . The American Gastroenterological Association has released new clinical guidelines on the management of patients ...

Female UC patients were 11% less likely to receive immunomodulator therapy compared to males. Women experienced 41% higher rates of UC-related hospitalizations than men. No significant sex-based ...

Living with ulcerative colitis means navigating a complex and often unpredictable digestive condition that impacts daily life in profound ways. This inflammatory bowel disease affects approximately 1 ...

The treatment of severe ulcerative colitis in pediatric patients presents a unique challenge to clinicians. In this Practice Point commentary we discuss the findings and limitations of a retrospective ...

Stress is an inevitable part of life, but it can impact everyone differently. In patients with ulcerative colitis, stress is a trigger that can lead to flares and worsening symptoms. That means ...

Ulcerative colitis is a chronic relapsing and remitting inflammatory disorder that can generally be managed successfully with maintenance oral medications. However, approximately 15% of patients with ...

1. The guideline focuses on using oral and topical 5-aminosalicylates medications, rectal corticosteroids and oral budesonide to provide high-quality care. 2. The guideline is intended for patients ...

A new drug improved management of ulcerative colitis, according to a study published in the New England Journal of Medicine. Patients treated with ozanimod, a sphongosine 1 phosphate receptor ...